Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAllergy/Clinical ImmunologyCurative Anaphylaxis Coverage Policy Update | Open…
    Ask Trek AI about this page
    CurrentCurativePolicy CHP-IP-2026-160

    F033. Anaphylaxis Requiring Hospital Care

    Customize your policy alerts

    Sign up for curative Policy CHP-IP-2026-160 alerts

    Get alerted when Policy CHP-IP-2026-160 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs observation, inpatient admission, continued stay, discharge readiness, and ICU, step-down, and medical-surgical level-of-care decisions for anaphylaxis from any trigger in patients of all ages. It excludes isolated urticaria or angioedema without systemic involvement and hereditary angioedema.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    PayerCurative
    PolicyF033. Anaphylaxis Requiring Hospital Care
    Policy CodePolicy CHP-IP-2026-160
    Change TypeNo material change
    Effective DateNot specified
    Next Review DateNot specified
    Key ActionDocument objective clinical severity findings and why required hospital-level services cannot safely be delivered in observation or outpatient care.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    All agesApplicable population
    24–48 hours or lessObservation period
    1–2 daysTypical inpatient stay
    Licensed physicianAdverse determination
    Each stay periodConcurrent review

    Hospital-Level Care Coverage Criteria

    Acute inpatient admission

    Acute inpatient admission is medically necessary when ALL of the following are met; otherwise, observation applies.

    Inpatient admission

    • Clinical severity finding

      • Hypotension (adult systolic blood pressure below 90 mmHg or more than 30% below baseline; age-specific thresholds apply in children) persists after initial intramuscular epinephrine and fluid bolus.
      • Refractory anaphylaxis requires an intravenous epinephrine infusion or additional vasopressor.
      • Persistent anaphylaxis has signs lasting 4 hours or more despite treatment.Signs lasting >=4 hours despite treatment
      • Upper-airway compromise, including stridor or progressive laryngeal or tongue angioedema, or hypoxemia with SpO2 below 92% after initial treatment, is present.SpO2 <92% after initial treatment
      • A biphasic reaction after initial resolution requires repeat epinephrine.
      • A severe initial reaction with cardiovascular or respiratory compromise, or more than one epinephrine dose, occurs in a patient with significant cardiovascular disease, severe or poorly controlled asthma, or beta-blocker therapy with inadequate response to epinephrine.
    • Hospital-level service required

      • Continuous cardiopulmonary monitoring with titrated intravenous epinephrine or vasopressor infusion is required.
      • Airway intervention or monitoring for progressive angioedema, including availability of advanced airway management, is required.
      • Intravenous glucagon is required for epinephrine-resistant anaphylaxis in a patient taking a beta-blocker.
      • Repeated intramuscular epinephrine or ongoing intravenous fluid resuscitation is required beyond the observation period.

    Observation or outpatient care

    Observation or outpatient care is appropriate when ANY of the following applies and no inpatient setting criterion is present.

    Observation or outpatient instead of inpatient

    • Non-severe anaphylaxis resolves after a single dose of epinephrine; symptoms fully resolve after observation.Observation commonly continues for about 1 hour after resolution for non-severe reactions
    • A severe reaction or two epinephrine doses completely resolves and requires extended observation for biphasic risk without ongoing hospital-level services.
    • Isolated cutaneous or mild gastrointestinal symptoms occur after allergen exposure without respiratory or cardiovascular involvement.

    Intensive care unit

    ICU care is appropriate when ANY of the following is documented.

    ICU level of care

    • Refractory anaphylaxis requires an epinephrine infusion or vasopressors, or airway compromise requires intubation or close airway monitoring.
    • A vasopressor or inotrope infusion is required to maintain mean arterial pressure of 65 mmHg or higher, or septic shock is present.MAP >=65 mmHg
    • Invasive mechanical ventilation or escalating noninvasive support is required for acute respiratory failure.SpO2 <90% despite FiO2 >=0.6, or pH <7.25 with rising PaCO2
    • Active hemorrhage with hemodynamic instability or massive transfusion protocol activation is present pending return to the operating room or angioembolization.

    Step-down or intermediate care

    Step-down or intermediate care is appropriate when ANY of the following is documented and no ICU criterion is present.

    • The patient is weaning from an epinephrine infusion, or persistent anaphylaxis requires repeated epinephrine with continuous monitoring.
    • NEWS2 is 5-6 or a single parameter score is 3, requiring vital signs at least every 1-2 hours without organ support.NEWS2 5-6 or single parameter score 3; vital signs at least every 1-2 hours
    • A new or hemodynamically significant arrhythmia requires continuous cardiac monitoring and rate-control titration.
    • Noninvasive ventilation or high-flow nasal oxygen is required in an otherwise stable patient, or obstructive sleep apnea with parenteral opioids requires continuous pulse oximetry and capnography.

    Medical-surgical unit

    Medical-surgical unit care is appropriate when ANY of the following applies.

    • Resolved anaphylaxis has an ongoing acute comorbid process, such as an asthma exacerbation requiring frequent bronchodilators, that independently requires hospital care.
    • The patient is hemodynamically stable with ongoing hospital-level postoperative services, such as parenteral or epidural analgesia, intravenous fluids or antibiotics, drain or wound management, or monitored advancement of diet.NEWS2 0-4 for the stable category
    • Vital signs every 4 hours are adequate and no ICU or step-down criterion is present.Vital signs every 4 hours

    Discharge readiness

    The patient is ready for discharge from acute care when ALL of the following are met.

    • Temperature is below 38.0 C for at least 24 hours, or a fever source is identified with an oral or outpatient treatment plan.Temperature <38.0 C for >=24 hours
    • Vital signs are stable on room air or at the baseline home oxygen requirement for at least 12-24 hours.NEWS2 0-4 for 12-24 hours
    • Pain is controlled on oral analgesics, with an opioid-sparing discharge regimen documented.
    • Oral fluids and diet are tolerated, or an enteral or parenteral nutrition plan is arranged.

    Continued-stay criteria

    Continued acute inpatient stay is medically necessary when ANY of the following is documented at each review.

    Continued stay

    • Any ICU or step-down level-of-care criterion is present, or NEWS2 is 5 or higher.NEWS2 >=5
    • Intravenous therapy cannot be given at a lower level of care, such as intravenous antibiotics without an oral or outpatient infusion option, initiation of parenteral nutrition, or intravenous analgesia.
    • Oral intake is not tolerated, or ileus requires nasogastric decompression.
    • An urgent procedure, imaging study, or consultation expected within 24 hours may change acute management.Expected within 24 hours

    Outside the scope of this policy: isolated urticaria or angioedema without systemic involvement and hereditary angioedema.

    Custodial, respite, convenience, or other non-acute days do not meet acute inpatient medical-necessity criteria.

    Inpatient admission is not medically necessary for non-severe anaphylaxis that resolves after one epinephrine dose and remains symptom-free after observation; observation or emergency department discharge is appropriate.

    Admission solely for prophylactic corticosteroids or antihistamines to prevent a biphasic reaction is not medically necessary as an inpatient service.

    A continued stay solely to await autoinjector supply or education after symptom resolution is not acute-level care; these arrangements should be completed at discharge.

    A preoperative admission more than one day before surgery for scheduling, travel, or convenience without a documented medical reason is not medically necessary. Preoperative evaluation and preparation can be completed as an outpatient.

    A continued stay after all discharge-readiness criteria are met is not acute-level care when the patient is only awaiting post-acute placement, transportation, or equipment without an acute need. Days already authorized are not reversed retroactively.

    Custodial, respite, or convenience days are not medically necessary at the acute inpatient level.

    Diagnosis, Facility, and Severity Coding

    ICD-10-CM: anaphylactic shock and food anaphylaxisICD-10
    T78.2XXAAnaphylactic shock
    T78.00XAFood anaphylaxis
    T78.01XAFood anaphylaxis
    T78.02XAFood anaphylaxis
    T78.03XAFood anaphylaxis
    T78.04XAFood anaphylaxis
    T78.05XAFood anaphylaxis
    T78.06XAFood anaphylaxis
    T78.09XAFood anaphylaxis
    ICD-10-CM: anaphylaxis due to vaccine, drug, blood product, or serumICD-10
    T80.52XAAnaphylaxis due to vaccine, drug, blood product, or serum
    T88.6XXAAnaphylaxis due to vaccine, drug, blood product, or serum
    T80.51XAAnaphylaxis due to vaccine, drug, blood product, or serum
    T80.59XAAnaphylaxis due to vaccine, drug, blood product, or serum
    MS-DRG FY2027 v44Revenue
    915Allergic reactions with MCC
    916Allergic reactions without MCC
    Revenue codes (facility)Revenue
    0120Facility revenue code
    0121Facility revenue code
    0200Facility revenue code
    0206Facility revenue code
    0250Facility revenue code
    0300Facility revenue code
    0762Facility revenue code
    Adult hypotension threshold
    Systolic blood pressureBelow 90 mmHg
    Relative declineMore than 30% below baseline
    Required contextPersists after initial intramuscular epinephrine and fluid bolus
    Hypoxemia threshold
    Oxygen saturation thresholdSpO2 below 92%
    TimingAfter initial treatment

    Review, Documentation, and Medical-Necessity Actions

    Denial Risk

    Physician Review for Adverse Determinations

    Only a licensed physician with the same or similar specialty may issue an adverse determination, after offering the requesting provider a peer-to-peer discussion. The reviewing physician must also meet applicable licensure, specialty, and medical-director requirements for the plan’s situs state.

    Documentation Required

    Concurrent Continued-Stay Review

    Concurrent review applies to each continued-stay period. An expected length of stay is a planning benchmark, not a limit on covered days, and days already authorized are not retroactively denied.

    Note

    Clinical Background

    Anaphylaxis is a serious, usually rapid-onset systemic hypersensitivity reaction that may be fatal. Intramuscular epinephrine is the first-line treatment. Biphasic reactions occur in approximately 5% of cases; persistent anaphylaxis lasts 4 hours or more despite treatment, and refractory anaphylaxis continues despite appropriate epinephrine and symptom-directed treatment. Most non-severe reactions that resolve promptly can be discharged after observation, while severe reactions, repeated epinephrine use, refractory or persistent symptoms, and significant cardiopulmonary comorbidity may require extended observation or admission.

    Policy Definitions

    Clinical severity findings
    DefinitionObjective, documented findings that establish the acuity of the condition
    Eligible evidenceExamination, vital signs, laboratory results, imaging, or validated scores
    Documentation standardFindings must be objective and documented
    Hospital-level services required
    DefinitionServices that cannot be delivered safely in observation, ambulatory, home, or post-acute settings
    ExamplesFrequent titration of intravenous therapy or continuous monitoring
    Additional example
    Policy Summary
    PayerCurative
    PolicyF033. Anaphylaxis Requiring Hospital Care
    Policy CodePolicy CHP-IP-2026-160
    Change TypeNo material change
    Effective DateNot specified
    Next Review DateNot specified
    Key ActionDocument objective clinical severity findings and why required hospital-level services cannot safely be delivered in observation or outpatient care.
    SourceLink
    On This Page
    Hospital-Level Care Coverage CriteriaDiagnosis, Facility, and Severity CodingReview, Documentation, and Medical-Necessity ActionsClinical BackgroundPolicy Definitions
  1. NEWS2 of 7 or higher persists after initial treatment, with physician documentation that organ support or continuous one-to-one monitoring is needed.NEWS2 >=7
  2. Hemoglobin is stable without transfusion for at least 24 hours, and creatinine and electrolytes are at or near baseline or have a follow-up plan.
  3. Mobility is at the expected post-procedure level, or transfer to a documented post-acute level of care is safe.
  4. A safe transition plan is documented, including medication reconciliation, venous thromboembolism prophylaxis, wound and drain instructions, return precautions, and follow-up appointment.
  5. The patient is symptom-free after the observation period appropriate to severity and has no epinephrine or vasopressor requirement.
  6. Two epinephrine autoinjectors are prescribed, with training, a written anaphylaxis emergency action plan, trigger-avoidance instructions, and allergist referral.
  7. Recurrent, biphasic, or persistent anaphylaxis, or continued epinephrine or vasopressor requirement, is present.
  8. Airway edema has not resolved.
  9. Clinical finding
    Hypoxemia meeting this threshold is a clinical severity finding for acute inpatient care
    Persistent anaphylaxis
    DurationSigns lasting 4 hours or more
    Treatment statusPersists despite treatment
    Clinical descriptionPersistent anaphylaxis
    NEWS2 ICU threshold
    NEWS2 score7 or higher
    PersistencePersists after initial treatment
    Required supportOrgan support or continuous one-to-one monitoring is needed, with physician documentation
    NEWS2 step-down threshold
    NEWS2 range5-6
    Single-parameter thresholdA single parameter score of 3
    Associated monitoringVital signs are needed at least every 1-2 hours without organ support
    Mean arterial pressure
    Mean arterial pressure65 mmHg or higher
    Clinical contextVasopressor or inotrope infusion is required to maintain this pressure
    Level of careThis finding supports ICU care when documented
    Acute respiratory failure thresholds
    Acute respiratory failureRequires invasive mechanical ventilation or escalating noninvasive support
    Oxygenation criterionSpO2 below 90% despite FiO2 of 0.6 or higher
    Ventilation criterionpH below 7.25 with rising PaCO2
    Expected observation stay
    Most casesObservation stay of less than 24 hours
    Inpatient refractory, persistent, or biphasic anaphylaxisTypically 1-2 days
    Use of length-of-stay figuresPlanning benchmark for concurrent review, not a limit on covered days
    Stable vital signs before discharge
    NEWS20-4
    Oxygen requirementRoom air or baseline home oxygen requirement
    Required durationStable for at least 12-24 hours

    Review When Criteria Are Silent

    The absence of a criterion addressing a service is not itself a basis for an adverse determination. A physician must review the request using generally accepted standards of medical practice.

    Documentation Required

    Document Clinical Severity Findings

    Document the objective clinical findings supporting severity and the requested level of care in the admission history and examination.

    • Vital signs and oxygen saturation
    • Laboratory and validated-score values
    • Other relevant objective findings
    Documentation Required

    Support Hospital-Level Service Need

    Document the hospital-level services ordered and why they cannot safely be delivered in observation or on an outpatient basis.

    Documentation Required

    Support the Level of Care

    Document the assigned level of care and the objective findings supporting ICU or step-down placement when either level is used.

    Documentation Required

    Document Continued-Stay Need

    For continued stays, provide daily progress notes showing current acuity and why acute care remains necessary.

    • Vital signs or NEWS2
    • Treatment changes
    • Specific reason acute care is still needed
    Documentation Required

    Complete Discharge Planning

    Document discharge readiness and the transition plan, including post-acute referral when applicable.

    Documentation Required

    Document Anaphylaxis Episode Details

    Document the details of the anaphylaxis episode to support the severity assessment and treatment provided.

    • Suspected trigger and timing
    • Organ systems involved and severity
    • Number and timing of epinephrine doses and the patient’s response
    Documentation Required

    Document Allergy Follow-Up

    When obtained, include the tryptase level in the record and document referral to an allergist for follow-up.

    • Tryptase result when obtained
    • Allergist referral
    Billing Rule

    Support the Requested Extent of Service

    The documentation must support the requested quantity, units, or duration. When only part of the request is supported, the supported portion is approved and only the unsupported increment is subject to review.

    Denial Risk

    Inpatient Criteria Not Met

    Inpatient medical necessity is not met for non-severe anaphylaxis that resolves after one epinephrine dose and remains symptom-free after observation. Observation or emergency department discharge is appropriate; the request is referred for physician review rather than denied by an automated system or non-physician reviewer.

    Denial Risk

    Prophylactic Medication Alone Does Not Support Admission

    An admission solely for prophylactic corticosteroids or antihistamines to prevent a biphasic reaction is not medically necessary at the inpatient level. These agents are not proven to prevent biphasic reactions.

    Denial Risk

    Non-Acute Continued Stay

    A continued stay after symptom resolution is not acute-level care when it is solely for awaiting an autoinjector supply or education. Complete these activities at discharge; similarly, days awaiting placement, transportation, equipment, or other convenience after discharge readiness do not support acute care.

    • Discharge readiness must be assessed and documented
    • Days already authorized are not reversed retroactively
    Denial Risk

    Avoid Unnecessary Preoperative Admission

    Preoperative admission more than one day before surgery for scheduling, travel, or convenience does not support medical necessity without a documented medical reason. Preoperative evaluation and preparation can be completed as an outpatient.

    Billing Rule

    Unsupported Quantity, Units, or Duration

    If the requested quantity, units, or duration exceed what the documentation supports, only the unsupported increment is reviewed; the supported portion is approved.

    Procedures with significant early complication risk
    Expected length of stay
    DefinitionA planning benchmark for an uncomplicated course
    ReferenceCMS FY2027 MS-DRG geometric mean length of stay
    Coverage significanceNot a limit on covered days
    NEWS2
    Full nameNational Early Warning Score 2
    ComponentsRespiratory rate, oxygen saturation, supplemental oxygen, systolic blood pressure, heart rate, level of consciousness, and temperature
    Clinical useA score of 5-6 or a single parameter score of 3 prompts urgent review; 7 or more prompts emergency response
    ASA physical status
    Full nameAmerican Society of Anesthesiologists physical status classification
    Class IIISevere systemic disease
    Class IVSevere systemic disease that is a constant threat to life